title: Beyond statins: what to expect from add-on lipid regulating therapy?
authors.affiliation: Klinik für Innere Meidizin III, Universitätsklinikum des Saalandes, Homburg D-66421, Germany.
authors.forename: Ulrich
authors.initials: U
authors.lastname: Laufs
authors.forename: William S
authors.initials: WS
authors.lastname: Weintraub
authors.forename: Chris J
authors.initials: CJ
authors.lastname: Packard
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000187:drug effects; D003327:Coronary Disease / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D058226:Plaque, Atherosclerotic / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D040242:Risk Reduction Behavior
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents